InvestorsHub Logo
Followers 37
Posts 2960
Boards Moderated 0
Alias Born 01/14/2003

Re: Larrybirdlegend post# 258150

Monday, 03/30/2020 8:05:52 PM

Monday, March 30, 2020 8:05:52 PM

Post# of 425847
amarin (for the time being possibly) lost their patent-protected monopoly to sell vascepa without generic competition in the US.

what could amarin do to generics to cause generics to be unprofitable to sell?

mochida epadel is sold over the counter.

no salesforce, just advertising.

It's the ratio, baby ... the EPA/AA ratio!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News